Warby Parker Inc.

NYSE:WRBY

Medical - Instruments & Supplies

Healthcare
$28.22 +3.78%

+$0.92 today

Market cap
$3.07B
Beta
1.97
P/E (TTM)
2305.1
EPS (TTM)
$0.01
52W Low $14.96High $31.00

Volume 5.90M

Average 2.81M

WRBY Net Receivables

Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.

Warby Parker Inc.NYSE: WRBY

Net Receivables · Q2 FY2026 · quarter ended Jun 2026

Net receivables rises 82.6% from a year ago

Net receivables stood at $2.08M at the end of Q2 FY2026, up 82.6% from a year earlier and up 18.1% from the prior quarter. Over 3 fiscal years it compounded at +31.8% a year.

Context

  • Net receivables amounted to 0.3% of total assets at the end of Q2 FY2026, up 0.1 pp from a year earlier.
  • Net receivables increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether net receivables keeps rising in the next quarterly balance sheet after a +82.6% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$2.08M+18.1% QoQ
Last fiscal yearDec 2025
$3.29M+68.6% YoY
Year agoJun 2025
$1.14M+82.6% since
Net Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+82.6%——
1 year+68.6%——
3-year CAGR+31.8%——
5-year CAGR——
10-year CAGR——

Net Receivables history

USD · from the balance sheet

Latest · FY2025
3.29M USD
Year-over-year change
+68.6%
4-year CAGR
+34.9%

Net Receivables vs competitors

How WRBY compares with its peers on the latest reported figures

  • WRBY's Jun 2026 net receivables of $2.08M is the 9th highest of the 10 companies compared; the peer median is $320.26M.
  • Its year-over-year change of +82.6% is the highest of 9, against a peer median of +2.7%.
  • Net receivables amounts to 0.3% of total assets for WRBY, versus a peer median of 9.1%.
WRBY Competitors Peer median
Net Receivables for WRBY and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
BHCBausch Health Companies Inc.Jun 2026$2.26B +2.4%+9.4%9.1%
XRAYDENTSPLY SIRONA Inc.Mar 2026$622M +3.0%+0.1%11.9%
QDELQuidelOrtho CorporationMar 2026$486.7M +11.4%-10.7%8.6%
ITGRInteger Holdings CorporationJul 2026$338.73M -16.5%+5.1%9.9%
CONConcentra Group Holdings Parent, Inc.Sep 2026$320.26M +14.8%+7.7%10.6%
ICUIICU Medical, Inc.Jun 2026$218.64M -0.2%-9.9%5.5%
HAEHaemonetics CorporationJun 2026$216.07M +7.6%+6.6%9.1%
LMATLeMaitre Vascular, Inc.Mar 2026$35.77M +1.9%+15.1%5.7%
WRBYWarby Parker Inc.Jun 2026$2.08M +82.6%+31.8%0.3%
BEAMBeam Therapeutics Inc.Jun 2026$0 ——0.0%
Peer median (excluding WRBY) $320.26M+2.7%+5.8%9.1%

Competitors are the stored peer set for WRBY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents256.42M208.59M216.89M254.16M286.36M
Short-term Investments00000
Net Receivables992K1.44M1.78M1.95M3.29M
Inventory57.1M68.85M62.23M52.35M44.51M
Other Current Assets015.7M17.71M17.59M18.28M
Total Current Assets327.98M294.57M298.62M326.05M352.44M
Property, Plant & Equipment (Net)112.2M265.64M274.64M341.75M358.25M
Goodwill00000
Intangible Assets8.6M0000
Long-term Investments0002M0
Tax Assets00000
Other Non-current Assets(8.13M)8.5M7.06M6.7M10.23M
Total Non-current Assets112.67M274.14M281.69M350.44M368.48M
Total Assets440.65M568.71M580.31M676.49M720.92M
Account Payables30.89M20.79M22.46M23.52M31.98M
Short-term Debt00000
Tax Payables00000
Deferred Revenue22.07M25.63M31.62M32.36M33.87M
Other Current Liabilities53.29M2.37M2.41M2.63M3.66M
Total Current Liabilities118.1M129.56M127.09M130.35M150.13M
Long-term Debt0000201.75M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities36.54M1.67M1.26M943K1.31M
Total Non-current Liabilities36.54M152.5M151.44M206.06M203.06M
Total Liabilities154.65M282.06M278.53M336.42M353.19M
Common Stock11K12K12K12K12K
Retained Earnings(493.24M)(603.63M)(666.83M)(687.22M)(685.58M)
Accumulated OCI16K(647K)(1.53M)(1.94M)(1.48M)
Other Stockholders Equity00000
Minority Interest00000
Total Equity286M286.65M301.79M340.07M367.73M
Total Debt0173.38M174.46M225.36M233.15M
Net Debt(256.42M)(35.21M)(42.44M)(28.81M)(53.21M)

Warby Parker Inc.

NYSE:WRBY

Intrinsic Alpha fair value

Locked

Current Price

$28.22

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.